{
    "title": "Corporate America weighs risks of the Ozempic effect",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12649081/Corporate-America-weighs-risks-Ozempic-effect.html",
    "date": "2023-10-19",
    "keywords": [
        "weightloss",
        "popularity",
        "use",
        "impact",
        "food",
        "ozempic",
        "demand",
        "beverage",
        "class",
        "health",
        "year",
        "officer",
        "dialysis",
        "kidney",
        "drug",
        "market",
        "insulin",
        "investor",
        "risk",
        "glp1",
        "wegovy",
        "lillys",
        "blood",
        "sugar",
        "weight",
        "portion",
        "change",
        "consumption",
        "wellness",
        "half",
        "hugh",
        "johnston",
        "company",
        "care",
        "effect",
        "future",
        "davita",
        "disease",
        "device",
        "slowdown",
        "companys",
        "joseph",
        "wolk",
        "hip",
        "knee",
        "monitoring",
        "ceo",
        "robert",
        "ford",
        "term",
        "insulet",
        "corp",
        "mounjaro",
        "time",
        "maker",
        "surgical",
        "mckesson",
        "boost",
        "bhanvi",
        "satija",
        "bengaluru",
        "editing",
        "mrigank",
        "dhaniwala"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}